Cargando…
Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
Prostate cancer invokes major shifts in gene transcription and metabolic signaling to mediate alterations in nutrient acquisition and metabolic substrate selection when compared to normal tissues. Exploiting such metabolic reprogramming is proposed to enable the development of targeted therapies for...
Autores principales: | Fidelito, Gio, Watt, Matthew J., Taylor, Renea A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813754/ https://www.ncbi.nlm.nih.gov/pubmed/35127483 http://dx.doi.org/10.3389/fonc.2021.778761 |
Ejemplares similares
-
Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022) -
Linking obesogenic dysregulation to prostate cancer progression
por: Taylor, Renea A, et al.
Publicado: (2015) -
To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013) -
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
por: Wang, Wanyan, et al.
Publicado: (2021) -
Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
por: Ng, Thomas S. C., et al.
Publicado: (2021)